MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jnnp-2014-309730

Медицинская библиотека · Journal of neurology, neurosurgery, and psychiatry · 2015

Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy.

Antoine Jean-Christophe, Boutahar Nadia, Lassablière François, Reynaud Evelyne, Ferraud Karine, Rogemond Véronique, Paul Stéphane, Honnorat Jérôme, Camdessanché Jean-Philippe

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Immunological mechanisms are suspected in sensory neuropathy (SN) occurring with systemic autoimmune diseases and in some idiopathic cases, but so far there are no antibodies (Abs) identifying these neuropathies.

METHODS

In the search for such specific antibodies, serum samples were collected from 106 patients with SN of these 72 fulfilled the diagnosis criteria of sensory neuronopathy (SNN) and 211 control subjects including patients with sensorimotor neuropathies, other neurological diseases (ONDs), systemic autoimmune diseases and healthy blood donors.

RESULTS

In the first step, a protein array with 8000 human proteins allowed identification of the intracellular domain of the fibroblast growth factor receptor 3 (FGFR3) as a target of Abs in 7/16 SNN and 0/30 controls. In the second step, an ELISA method was used to test the 317 patients and controls for anti-FGFR3 Abs. Abs were detected in 16/106 patients with SN and 1/211 controls (p<0.001). Among the 106 patients with SN, anti-FGFR3 Abs were found in 11/38 patients with autoimmune context, 5/46 with idiopathic neuropathy and 0/22 with neuropathy of other aetiology (p=0.006). The only control patient with anti-FGFR3 Abs had lupus and no recorded neuropathy. Sensitivity, specificity, and positive and negative predictive values of anti-FGFR3 Abs for a diagnosis of idiopathic or dysimmune SN were 19%, 99.6%, 94.1% and 77.3%, respectively. A cell-based assay confirmed serum reactivity against the intracellular domain of FGFR3. The neuropathy in patients with anti-FGF3 Abs was non-length dependent in 87% of patients and fulfilled the criteria of probable SNN in 82%. Trigeminal nerve involvement and pain were frequent features.

CONCLUSIONS

A anti-FGFR3 Abs identify a subgroup of patients with SN in whom an underlying autoimmune disorder affecting sensory neurons in the dorsal root and trigeminal nerve ganglia is suspected.

Для цитирования: Antoine Jean-Christophe, Boutahar Nadia, Lassablière François, Reynaud Evelyne, Ferraud Karine, Rogemond Véronique, Paul Stéphane, Honnorat Jérôme, Camdessanché Jean-Philippe. Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy.. Journal of neurology, neurosurgery, and psychiatry. 2015. DOI: 10.1136/jnnp-2014-309730.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.